Yahoo
Tokyo - Delayed Quote JPY

Sugi Holdings Co.,Ltd. (7649.T)

1,304.50 +18.50 (+1.44%)
At close: October 30 at 3:30:00 PM GMT+9
Chart Range Bar
Loading chart for 7649.T
  • Previous Close 1,286.00
  • Open 1,300.50
  • Bid 1,303.00 x --
  • Ask 1,305.00 x --
  • Day's Range 1,295.50 - 1,310.00
  • 52 Week Range 1,193.50 - 1,991.00
  • Volume 1,614,100
  • Avg. Volume 2,335,628
  • Market Cap (intraday) 485.506B
  • Beta (5Y Monthly) 0.29
  • PE Ratio (TTM) 16.12
  • EPS (TTM) 80.90
  • Earnings Date (est.) Jan 7, 2027
  • Forward Dividend & Yield 17.50 (1.34%)
  • Ex-Dividend Date Feb 25, 2027
  • 1y Target Est 1,591.67

Sugi Holdings Co.,Ltd. operates drugstores in Japan. The company also provides self-care support services, including meal delivery, cancer and other health checkups, specific health guidance, health information, and community comprehensive agreements; home-visit dispensing and nursing, prevention programs, shopping assistance, and mobility support services. In addition, it engages in drugstore operation, dispensing pharmacy operation, medical consultation, business in foreign countries, Chinese medicine pharmacy operations, disease prevention and health support, promotion of disabled employment, home visit nursing and elderly home-care support, support for commencement of medical practice, comprehensive staff agency service, and support business for pharmacy operations. Sugi Holdings Co.,Ltd. was founded in 1976 and is headquartered in Obu, Japan.

www.sugi-hd.co.jp

13,417

Full Time Employees

February 28

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

7649.T
28.40%
Nikkei 225 (^N225)
25.73%

1-Year Return

7649.T
20.46%
Nikkei 225 (^N225)
23.31%

3-Year Return

7649.T
37.64%
Nikkei 225 (^N225)
106.18%

5-Year Return

7649.T
1.84%
Nikkei 225 (^N225)
119.05%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY27
Revenue 270.54B
Earnings 6.09B
Profit Margin 2.25%

Q3

FY26

Q4

FY26

Q1

FY27

Q2

FY27

0
50B
100B
150B
200B
250B
2.5%
3.0%
3.5%

Analyst Insights

View More

Analyst Price Targets

1,250.00
1,591.67 Average
1,304.50 Current
1,900.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.79%

  • Return on Assets (ttm)

    5.29%

  • Return on Equity (ttm)

    9.90%

  • Revenue (ttm)

    1.05T

  • Net Income Avi to Common (ttm)

    29.35B

  • Diluted EPS (ttm)

    80.90

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    118.59B

  • Total Debt/Equity (mrq)

    29.05%

  • Levered Free Cash Flow (ttm)

    -8.92B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: